1. Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group. (October 2022) Authors: Antonarelli, Gabriele; Corti, Chiara; Zucali, Paolo Andrea; Perrino, Matteo; Manglaviti, Sara; Lo Russo, Giuseppe; Varano, Gianluca Maria; Salvini, Piermario; Curigliano, Giuseppe; Catania, Chiara; Conforti, Fabio; De Pas, Tommaso Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-19. TEM-GBM: A PHASE I-IIA DOSE-ESCALATION STUDY DELIVERING IFN-Α WITHIN GLIOBLASTOMA MULTIFORME TUMOR MICROENVIRONMENT BY GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES. (12th November 2021) Authors: Finocchiaro, Gaetano; Gentner, Bernhard; Marica, Eoli; Francesca, Farina; Capotondo, Alessia; Ferla, Valeria; Carrabba, Matteo; Cuccarini, Valeria; Meco, Francesco Di; Legnani, Federico; Pollo, Bianca; Saini, Marco; Ferroli, Paolo; Pallini, Roberto; D'Alessandris, Giorgio; Patanè, Monica; Paterra... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67?. Issue 3 (March 2022) Authors: Antonarelli, Gabriele; Valenza, Carmine; Mayer, Erica L; Loibl, Sibylle; Curigliano, Giuseppe Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Emerging treatment landscape of non-muscle invasive bladder cancer. (3rd June 2022) Authors: Valenza, Carmine; Antonarelli, Gabriele; Giugliano, Federica; Aurilio, Gaetano; Verri, Elena; Briganti, Alberto; Curigliano, Giuseppe; Necchi, Andrea Journal: Expert opinion on biological therapy Issue: Volume 22:Number 6(2022) Page Start: 717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Harmonizing PD-L1 testing in metastatic triple negative breast cancer. (4th March 2022) Authors: Giugliano, Federica; Antonarelli, Gabriele; Tarantino, Paolo; Cortes, Javier; Rugo, Hope S.; Curigliano, Giuseppe Journal: Expert opinion on biological therapy Issue: Volume 22:Number 3(2022) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Histology-agnostic approvals for antibody–drug conjugates in solid tumours: is the time ripe?. (August 2022) Authors: Corti, Chiara; Antonarelli, Gabriele; Valenza, Carmine; Nicolò, Eleonora; Rugo, Hope; Cortés, Javier; Harbeck, Nadia; Carey, Lisa A.; Criscitiello, Carmen; Curigliano, Giuseppe Journal: European journal of cancer Issue: Volume 171(2022) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT. (21st September 2021) Authors: Finocchiaro, Gaetano; Eoli, Marica; Gentner, Bernhard; Capotondo, Alessia; Anghileri, Elena; Antonarelli, Gabriele; Barcella, Matteo; Bruzzone, Maria Grazia; Carrabba, Matteo; Cuccarini, Valeria; D'Alessandris, Quintino G; DiMeco, Francesco; Farina, Francesca; Ferla, Valeria; Ferroli, Paolo; Gagl... Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy: early phase development. (3rd June 2022) Authors: Tarantino, Paolo; Antonarelli, Gabriele; Ascione, Liliana; Curigliano, Giuseppe Journal: Expert opinion on investigational drugs Issue: Volume 31:Number 6(2022) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses. Issue 10 (30th August 2021) Authors: Mucci, Adele; Antonarelli, Gabriele; Caserta, Carolina; Vittoria, Francesco Maria; Desantis, Giacomo; Pagani, Riccardo; Greco, Beatrice; Casucci, Monica; Escobar, Giulia; Passerini, Laura; Lachmann, Nico; Sanvito, Francesca; Barcella, Matteo; Merelli, Ivan; Naldini, Luigi; Gentner, Bernhard Journal: EMBO molecular medicine Issue: Volume 13:Issue 10(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targeting brain metastases in breast cancer. (February 2022) Authors: Corti, Chiara; Antonarelli, Gabriele; Criscitiello, Carmen; Lin, Nancy U.; Carey, Lisa A.; Cortés, Javier; Poortmans, Philip; Curigliano, Giuseppe Journal: Cancer treatment reviews Issue: Volume 103(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗